Journal of Nutrition EB Program 2010 Early Registration

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Renwick, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Renwick, A. G.

© 2003 The American Society for Nutritional Sciences J. Nutr. 133:2031S-2033S, June 2003


Supplement: 2nd Amino Acid Workshop

The Safety Testing of Amino Acids1

Andrew G. Renwick2

Clinical Pharmacology Group, University of Southampton, Biomedical Sciences Building, Southampton SO16 7PX, UK

2 To whom correspondence should be addressed. E-mail: agr{at}soton.ac.uk.

The risk assessment of compounds added to foods or taken as supplements is usually based on hazard characterization studies performed in animal test species. A large default uncertainty factor, or margin or exposure, is usually required to allow for possible species differences and human variability in the toxicokinetics and toxicodynamics of the compound. The development of biomarkers offers the potential to rationalize the risk assessment of amino acids, and to refine the extrapolation of data from animals to humans. The use of high resolution nuclear magnetic resonance spectroscopy applied to readily accessible biological fluids, such as urine and plasma, offers great potential for the identification of toxicologically relevant biomarkers in animal studies that can then be applied to studies in humans.


KEY WORDS: • amino acids • risk assessment • biomarkers • metabonomics • toxicokinetics




This article has been cited by other articles:


Home page
J. Nutr.Home page
L. Cynober
Introduction to the 5th Amino Acid Assessment Workshop.
J. Nutr., June 1, 2006; 136(6 Suppl): 1633S - 1635S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Toue, R. Kodama, M. Amao, Y. Kawamata, T. Kimura, and R. Sakai
Screening of Toxicity Biomarkers for Methionine Excess in Rats
J. Nutr., June 1, 2006; 136(6): 1716S - 1721S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W. M. Rand
Variability in Planning and Assessment: Statistical Considerations and Models
J. Nutr., June 1, 2004; 134(6): 1610S - 1616S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Sakai, M. Miura, M. Amao, R. Kodama, S. Toue, Y. Noguchi, and T. Kimura
Potential Approaches to the Assessment of Amino Acid Adequacy in Rats: A Progress Report
J. Nutr., June 1, 2004; 134(6): 1651S - 1655S.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2003 by American Society for Nutrition